← Back to Search

Survivorship and Palliative Care Model for Lung Cancer

N/A

Recruiting

Led By Laura A Petrillo, MD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Receiving targeted therapy

Age 18 or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 20 weeks

Awards & highlights

Study Summary

This trial is developing a care model to help people with metastatic lung cancer cope with uncertainty and understand their prognosis and treatment goals, so they can live well with cancer.

Who is the study for?

This trial is for adults diagnosed with metastatic Non-small Cell Lung Cancer (NSCLC) within the last 6 months, who are receiving targeted therapy and can communicate in English or Spanish. It's specifically for patients at MGH Cancer Center. Pregnant women, prisoners, those needing urgent palliative care, or individuals with cognitive impairments that prevent informed consent are excluded.Check my eligibility

What is being tested?

The study is testing a new supportive care model called POISE designed for NSCLC patients. POISE involves four sessions with a trained clinician compared to standard care. The focus is on its feasibility, acceptability, and impact on patient distress about their future, cancer management confidence, and understanding of what to expect.See study design

What are the potential side effects?

Since POISE is a supportive care model rather than a medication or medical procedure, it does not have traditional side effects. However, discussing serious illness may cause emotional discomfort or distress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am currently on targeted therapy for my condition.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 20 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~20 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility of POISE

Secondary outcome measures

Acceptability

Distress related to prognostic uncertainty

Documentation of Goals and Values

+1 more

Other outcome measures

Psychological Distress

Uncertainty tolerance

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: POISEExperimental Treatment1 Intervention

The intervention will be a structured palliative care intervention in which patients will meet with a palliative care clinician who has been trained on a manual with specific topics to be covered in each of the four visits: Three surveys: baseline, 12-week, and 20-week post-enrollment Four 60-minute visits with a trained palliative care clinician Semi-structured exit interview Chart review

Group II: Usual careActive Control1 Intervention

Patients randomized to usual care will receive usual oncology care. They may access standard palliative care as clinically indicated.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

American Lung AssociationOTHER

31 Previous Clinical Trials

10,883 Total Patients Enrolled

Massachusetts General HospitalLead Sponsor

2,935 Previous Clinical Trials

13,198,551 Total Patients Enrolled

Laura A Petrillo, MDPrincipal InvestigatorMassachusetts General Hospital

1 Previous Clinical Trials

210 Total Patients Enrolled

Media Library

POISE Clinical Trial Eligibility Overview. Trial Name: NCT04900935 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there open slots available for the current clinical trial?

"Clinicaltrials.gov indicates that this particular medical trial, which was first announced on October 1st 2022, is not presently seeking participants. Nonetheless, there are 2140 other studies currently recruiting patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Patient-centered, Optimal Integration of Survivorship and Palliative Care

Laura Petrillo, M.D. 2023. "Patient-centered, Optimal Integration of Survivorship and Palliative Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04900935.

All > Non Small Cell Lung Cancer